Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial

Samuel Z. Goldhaber, Craig M. Kessler, John A. Heit, C. Gregory Elliott, William R. Friedenberg, Darell E. Heiselman, David B. Wilson, John Anthony Parker, Don Bennett, Michael L. Feldstein, Andrew P. Selwyn, Ducksoo Kim, G. V.R.K. Sharma, James S. Nagel, Michael F. Meyerovitz

Research output: Contribution to journalArticlepeer-review

185 Scopus citations

Fingerprint Dive into the research topics of 'Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial'. Together they form a unique fingerprint.

Medicine & Life Sciences